Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SPNS
stocks logo

SPNS

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
140.13M
+2.43%
0.320
-13.58%
147.89M
+7.93%
0.346
-6.42%
151.34M
+12.69%
0.371
+0.27%
Estimates Revision
The market is revising Upward the revenue expectations for Sapiens International Corporation N.V. (SPNS) for FY2025, with the revenue forecasts being adjusted by 2.73% over the past three months. During the same period, the stock price has changed by 14.74%.
Revenue Estimates for FY2025
Revise Upward
up Image
+2.73%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-3.25%
In Past 3 Month
Stock Price
Go Up
up Image
+14.74%
In Past 3 Month
4 Analyst Rating
up Image0
Wall Street analysts forecast SPNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPNS is 30.67 USD with a low forecast of 26.00 USD and a high forecast of 35.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
2 Sell
Hold
up Image0
Current: 29.820
sliders
Low
26.00
Averages
30.67
High
35.00
up Image0
Current: 29.820
sliders
Low
26.00
Averages
30.67
High
35.00
Barclays
Underweight
maintain
$28 -> $31
2025-05-09
Reason
Barclays
Price Target
$28 -> $31
2025-05-09
maintain
Underweight
Reason
Barclays raised the firm's price target on Sapiens to $31 from $28 and keeps an Underweight rating on the shares post the Q1 report. Sapiens is continuing with its strategy-optimizing product offerings and leveraging its existing customer base, this quarter making two acquisitions, the analyst tells investors in a research note. The firm thinks it is too early to become constructive on the shares.
Barclays
Tavy Rosner
Sell
Maintains
$30 → $28
2025-02-19
Reason
Barclays
Tavy Rosner
Price Target
$30 → $28
2025-02-19
Maintains
Sell
Reason
Barclays lowered the firm's price target on Sapiens to $28 from $30 and keeps an Underweight rating on the shares following the Q4 report. The firm says 2025 looks like a transition year for the company as management invests in generating higher growth through optimizing product offering, and leveraging its existing customer base.
Needham
Mayank Tandon
Strong Buy
Reiterates
$35
2025-02-19
Reason
Needham
Mayank Tandon
Price Target
$35
2025-02-19
Reiterates
Strong Buy
Reason
Jefferies
Surinder Thind
Strong Buy
to
Hold
Downgrades
$36 → $28
2025-02-03
Reason
Jefferies
Surinder Thind
Price Target
$36 → $28
2025-02-03
Downgrades
Strong Buy
to
Hold
Reason
Needham
Mayank Tandon
Strong Buy
Maintains
$44 → $35
2024-11-12
Reason
Needham
Mayank Tandon
Price Target
$44 → $35
2024-11-12
Maintains
Strong Buy
Reason
Barclays
Tavy Rosner
Sell
Maintains
$38 → $30
2024-11-12
Reason
Barclays
Tavy Rosner
Price Target
$38 → $30
2024-11-12
Maintains
Sell
Reason
Barclays lowered the firm's price target on Sapiens to $30 from $38 and keeps an Underweight rating on the shares. The company's lower than expected revenue and outlook were attributed to delays in software-as-a-service deal closings, among other things, the analyst tells investors in a research note. The firm reduced estimates post the print.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Sapiens International Corporation NV (SPNS.O) is 20.94, compared to its 5-year average forward P/E of 2.96. For a more detailed relative valuation and DCF analysis to assess Sapiens International Corporation NV 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
2.96
Current PE
20.94
Overvalued PE
10.03
Undervalued PE
-4.10

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
15.35
Current EV/EBITDA
14.93
Overvalued EV/EBITDA
18.51
Undervalued EV/EBITDA
12.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.04
Current PS
2.82
Overvalued PS
3.60
Undervalued PS
2.49

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 200% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

SPNS News & Events

Events Timeline

(ET)
2025-05-08
06:23:09
Sapiens raises FY25 revenue view to $574M-$578M from $553M-$558M
select
2025-05-08
06:21:07
Sapiens reports Q1 EPS 37c, consensus 35c
select
2025-04-28 (ET)
2025-04-28
13:33:17
Sapiens agrees to acquire AdvantageGo
select
Sign Up For More Events
Sign Up For More Events

News

Preview
4.0
07-09Newsfilter
Sapiens Named as an AI Decisioning Platform leader in Analyst Evaluation

  • Sapiens Decision Recognition: Sapiens International Corporation's AI Decisioning Platform, Sapiens Decision, has been named a Leader in The Forrester Wave™: AI Decisioning Platforms for Q2 2025, highlighting its capabilities in serving highly regulated industries like insurance and financial services.

  • Commitment to AI Excellence: The recognition underscores Sapiens' commitment to operational excellence and business agility through AI decisioning, offering organizations scalable solutions that enhance decision-making while managing AI risks effectively.

Preview
4.0
07-09Newsfilter
S&P Global Ratings Maalot Confirms Ratings of Sapiens and its Series B Debentures as "ilAA-" with a Stable Outlook/ "ilAA-"

  • Sapiens International Corporation Rating Confirmation: Sapiens has received a long-term issuer rating of "ilAA-" with a stable outlook from Ma'alot S&P Global, reflecting confidence in the company's growth and financial performance.

  • Company Overview: Sapiens is a global provider of SaaS-based software solutions for the insurance industry, serving over 600 customers in more than 30 countries, and is recognized for its innovative offerings and commitment to customer success.

Preview
3.5
06-23Newsfilter
Absa Life Goes Live with Sapiens Insurance Platform to Modernize Core Systems and Enhance Customer Journeys

  • Absa Life's Transformation: Absa Life has successfully implemented the Sapiens Insurance Platform, which includes various integrated solutions aimed at modernizing its operations, enhancing customer experience, and supporting future AI-driven innovations.

  • Partnership with Sapiens: The collaboration between Absa Life and Sapiens is focused on building a more agile insurance business capable of quickly adapting to market demands, with new AI models being developed to provide real-time insights and predictive capabilities.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Sapiens International Corporation NV (SPNS) stock price today?

The current price of SPNS is 29.82 USD — it has increased 0.71 % in the last trading day.

arrow icon

What is Sapiens International Corporation NV (SPNS)'s business?

Sapiens International Corporation N.V.is an Israel-based company engaged primary in the provision of software solutions for the insurance industry. The Company develops and maintains software for insurance companies, that helps resolving various general and market specific tasks related to the insurance sector. The Company's software is using artificial intelligence (AI) as well as advanced automation to resolve the tasks. The Company's software helps in a range of tasks such as: supporting core solutions for property and casualty, maintenance of workers compensation, financial and compliance, data and analytics, and decision management besides others. The Company is cooperating with specialists in information technology (IT) as well as insurance sectors.

arrow icon

What is the price predicton of SPNS Stock?

Wall Street analysts forecast SPNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPNS is 30.67 USD with a low forecast of 26.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Sapiens International Corporation NV (SPNS)'s revenue for the last quarter?

Sapiens International Corporation NV revenue for the last quarter amounts to 136.11M USD, increased 1.38 % YoY.

arrow icon

What is Sapiens International Corporation NV (SPNS)'s earnings per share (EPS) for the last quarter?

Sapiens International Corporation NV. EPS for the last quarter amounts to 0.32 USD, increased 3.23 % YoY.

arrow icon

What changes have occurred in the market's expectations for Sapiens International Corporation NV (SPNS)'s fundamentals?

The market is revising Upward the revenue expectations for Sapiens International Corporation N.V. (SPNS) for FY2025, with the revenue forecasts being adjusted by 2.73% over the past three months. During the same period, the stock price has changed by 14.74%.
arrow icon

How many employees does Sapiens International Corporation NV (SPNS). have?

Sapiens International Corporation NV (SPNS) has 4850 emplpoyees as of July 17 2025.

arrow icon

What is Sapiens International Corporation NV (SPNS) market cap?

Today SPNS has the market capitalization of 1.67B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free